Bioinformatics

Bioinformatics is at the cutting edge of modern life sciences, driving innovation across diagnostics, therapeutics, and personalised medicine. By harnessing biological data and applying computational tools, researchers are uncovering new insights into disease, developing in silico drug discovery platforms, and predicting patient outcomes with unprecedented precision.

Protecting these innovations requires a sophisticated intellectual property strategy that understands both biological complexity and software-driven processes. HGF has a long-standing reputation for IP excellence in life sciences and data-centric technologies, making us ideally placed to support bioinformatics innovators.

Our expertise includes:

  • AI and machine learning models trained on biological data
  • Genomic analysis and personalised medicine platforms
  • Computational biology tools and software pipelines
  • Data integration, visualisation, and analytics systems
  • Expert guidance on patentability of algorithms, databases and diagnostic methods under European patent law
  • Coordinating parallel patent strategies across EP, national and international filing routes

From spinouts leveraging university research to global pharmaceutical companies developing next-generation therapies, we work with a broad range of clients to protect core technologies and support commercial success.

We understand the particular challenges of patenting bioinformatics inventions, from hybrid software/biotech technologies to patentability requirements in software and AI innovations. Our attorneys provide commercially focused IP strategies that align with your R&D roadmap, regulatory environment, and funding goals.

Our integrated approach draws on a wealth of technical and legal knowledge across disciplines, combining life sciences, software, and medical regulation expertise. We offer a full suite of IP protection tools, including patents, trade secrets, copyright, and database rights.

At HGF, we don’t just file patents, we help shape your competitive advantage in a fast-evolving market. Partner with us for IP strategies that secure your position at the forefront of bioinformatics innovation.

Latest updates

PRESS RELEASE - Oliver Pooley joins HGF as a Partner 21st April 2026

HGF is pleased to announce the appointment of Oliver Pooley who will be joining the firm as a Partner on 21st April 2026. Oliver joins our Technology & Engineering Group …

Read article
Event - 16th April 2026

MedTech Innovation Summit 2026

HGF Partner and Patent Attorney Adam Hines will be attending the MedTech Innovation Summit Dublin 2026, taking place from 28–30 April at The Shelbourne Hotel. As one of Europe’s premier …

Event details

Fuelling IP: Will Oil and Gas Price Shocks Heat or Cool the Energy IP Landscape?

Explosive volatility in energy prices Recent developments in the Middle East have once again highlighted the fragility of global energy markets. Disruption to Liquified Natural Gas (LNG) and oil transit …

Read article

Can simulations/modelling be patentable?

Simulations and modelling are core products across many industries, including energy, automotive, and AI. This drives a high volume of patent filings. However, their patentability is often unclear because Article …

Read article

AI, Biotech and trade secrets

In this episode of HGF Presents, Amy Dawson and Jess Davis explore how artificial intelligence is opening new possibilities in the biotechnology sector and how trade secrets can be used …

Read article

New Blog Post - Fuelling IP: Five Common Mistakes Energy Innovators Make When Protecting Intellectual Property (IP)

How to avoid undervaluing, under protecting or overlooking critical innovation in the energy sector. Energy companies are being forced to innovate faster than ever, or risk missing out on massive …

Read article

European Drone Companies, Where are Your Patents?

With significant consolidations occurring in the drone and eVTOL sectors, some European companies look set to miss out through a failure of IP strategy. Innovations and technology often account for …

Read article

A New Era for AI Patents in the UK: Supreme Court Aligns with the EPO

The UK Supreme Court has handed down its long-awaited judgment in Emotional Perception AI Limited (EPAI) vs Comptroller General of Patents, a decision which serves to significantly change the way …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our bioinformatics specialists.